Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04549155 · ClinicalTrials.gov registry record · NA
Network-guided TMS in Early Alzheimer's Disease
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT04549155 is a NA study that has completed, run by Duke University. The registered enrollment target is 37 participants.
The verdict
NCT04549155, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The proposed research will test a novel network-based neurostimulation approach using MRI-derived measures of brain connectivity to establish target sites for neurostimulation and test for the enhancement of memory function beyond a sham stimulation condition. This will be tested in cohort of MCI adults using network-based transcranial magnetic stimulation (TMS) to assess for behavioral improvement due to the controlled intervention. This study will provide important evidence towards the efficacy of neuromodulatory treatments for memory decline and will accelerate the discovery of potent non-invasive treatments to remediate cognitive decline in cognitively impaired older adults.
Interventions
- DEVICE Transcranial Magnetic Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2022-03-08 |
| Est. Completion | 2025-06-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04549155
The ClinicalTrials.gov registry entry for NCT04549155 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Magnetic Stimulation is the first listed.
NCT04549155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04549155 about?
NCT04549155 is a clinical study titled "Network-guided TMS in Early Alzheimer's Disease". The proposed research will test a novel network-based neurostimulation approach using MRI-derived measures of brain connectivity to establish target sites for neurostimulation and test for the enhancement of memory function beyond a sham stimulation condition. This will be tested in cohort of MCI ad...
What is the current status of trial NCT04549155?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2022-03-08. Estimated completion is 2025-06-27.
What interventions are being tested in trial NCT04549155?
The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE).
Who is sponsoring clinical trial NCT04549155?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.